Taccalonolide CCAS# 117803-96-0 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 117803-96-0 | SDF | Download SDF |
PubChem ID | 163003075.0 | Appearance | Powder |
Formula | C36H46O14 | M.Wt | 702.75 |
Type of Compound | Steroids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (4,11,15-triacetyloxy-22-hydroxy-12,16,18,21,22-pentamethyl-5,20,23-trioxo-9,24-dioxaheptacyclo[15.7.1.02,16.03,13.06,12.08,10.021,25]pentacosan-14-yl) acetate | ||
SMILES | CC1CC(=O)C2(C3C1C4(C(C3OC(=O)C2(C)O)C5C(C(C4OC(=O)C)OC(=O)C)C6(C(CC7C(C6OC(=O)C)O7)C(=O)C5OC(=O)C)C)C)C | ||
Standard InChIKey | RXQVUONAHNHYNF-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C36H46O14/c1-12-10-19(41)35(8)24-21(12)34(7)22(28(24)50-32(43)36(35,9)44)20-23(29(46-14(3)38)31(34)48-16(5)40)33(6)17(25(42)27(20)45-13(2)37)11-18-26(49-18)30(33)47-15(4)39/h12,17-18,20-24,26-31,44H,10-11H2,1-9H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Taccalonolide C Dilution Calculator
Taccalonolide C Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.423 mL | 7.1149 mL | 14.2298 mL | 28.4596 mL | 35.5745 mL |
5 mM | 0.2846 mL | 1.423 mL | 2.846 mL | 5.6919 mL | 7.1149 mL |
10 mM | 0.1423 mL | 0.7115 mL | 1.423 mL | 2.846 mL | 3.5575 mL |
50 mM | 0.0285 mL | 0.1423 mL | 0.2846 mL | 0.5692 mL | 0.7115 mL |
100 mM | 0.0142 mL | 0.0711 mL | 0.1423 mL | 0.2846 mL | 0.3557 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Syringopicroside
Catalog No.:BCX1194
CAS No.:29118-80-7
- Ludaconitine
Catalog No.:BCX1193
CAS No.:82144-72-7
- (-)-3-Demethylcolchicine
Catalog No.:BCX1192
CAS No.:7336-33-6
- Daucosterin acetate
Catalog No.:BCX1191
CAS No.:4282-00-2
- Deoxycytidine
Catalog No.:BCX1190
CAS No.:951-77-9
- Kissoone A
Catalog No.:BCX1189
CAS No.:903559-01-3
- Glycyrrhizic acid methyl ester
Catalog No.:BCX1188
CAS No.:104191-95-9
- Rubropunctamine
Catalog No.:BCX1187
CAS No.:514-66-9
- Neoisoliquiritigenin
Catalog No.:BCX1186
CAS No.:7014-39-3
- 6-Acetyl-7-hydroxy-2,3-dimethylchromone
Catalog No.:BCX1185
CAS No.:225518-70-7
- Heterophyllin J
Catalog No.:BCX1184
CAS No.:660397-15-9
- 5-Methoxyafrormosin 7-O-glucoside
Catalog No.:BCX1183
CAS No.:64656-92-4
- Complanatuside 6"-malonate
Catalog No.:BCX1196
CAS No.:2089462-18-8
- Resinacein C
Catalog No.:BCX1197
CAS No.:1309931-92-7
- Markogenin
Catalog No.:BCX1198
CAS No.:562-35-6
- 4α-Phorbol
Catalog No.:BCX1199
CAS No.:26241-63-4
- Alltride
Catalog No.:BCX1200
CAS No.:2050-87-5
- 21-keto-gypenoside A
Catalog No.:BCX1201
CAS No.:1392136-41-2
- Tigogenin lactone
Catalog No.:BCX1202
CAS No.:514-33-0
- 8-Keto-berberine
Catalog No.:BCX1203
CAS No.:81397-08-2
- Isoproprotogracillin B
Catalog No.:BCX1204
CAS No.:117457-34-8
- Iodixanol Impurity C
Catalog No.:BCX1205
CAS No.:171897-74-8
- Tarasaponin VI
Catalog No.:BCX1206
CAS No.:59252-95-8
- Crocin IV
Catalog No.:BCX1207
CAS No.:57710-64-2
Taccalonolide C-6 Analogues, Including Paclitaxel Hybrids, Demonstrate Improved Microtubule Polymerizing Activities.[Pubmed:34110822]
J Nat Prod. 2021 Jun 25;84(6):1799-1805.
The C-22,23-epoxy taccalonolides are microtubule stabilizers that bind covalently to beta-tubulin with a high degree of specificity. We semisynthesized and performed biochemical and cellular evaluations on 20 taccalonolide analogues designed to improve target engagement. Most notably, modification of C-6 on the taccalonolide backbone with the C-13 N-acyl-beta-phenylisoserine side chain of paclitaxel provided compounds with 10-fold improved potency for biochemical tubulin polymerization as compared to that of the unmodified epoxy taccalonolide AJ. Covalent docking demonstrated that the C-13 paclitaxel side chain occupied a binding pocket adjacent to the core taccalonolide pocket near the M-loop of beta-tubulin. Although paclitaxel-taccalonolide hybrids demonstrated improved in vitro biochemical potency, they retained features of the Taccalonolide Chemotype, including a lag in tubulin polymerization and high degree of cellular persistence after drug washout associated with covalent binding. Together, these data demonstrate that C-6 modifications can improve the target engagement of this covalent class of microtubule drugs without substantively changing their mechanism of action.